XOMA (US) LLC

Type: Company
Name: XOMA (US) LLC
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Insider Selling: John Varian Unloads 10,000 Shares of XOMA Corp Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) CEO John Varian sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 15th. The shares were sold at an average price of $4.06, for a total value of $40,600.00. Following the sale, the chief ... [Published American Banking News - 7 hours ago]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Short Interest in XOMA Corp Expands By 43.2% (XOMA)

XOMA Corp (NASDAQ:XOMA) saw a significant increase in short interest during the month of January. As of March 31st, there was short interest totalling 9,384,397 shares, an increase of 43.2% from the March 14th total of 6,552,758 shares, AmericanBankingNews.com ... [Published American Banking News - Apr 15 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Anthera Pharmaceuticals Announces Personnel Changes

By a News Reporter-Staff News Editor at Biotech Week -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced the appointment of Steven Engle ... [Published HispanicBusiness.com - Apr 10 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Anthera Pharmaceuticals : Reports Personnel Changes

Anthera Pharmaceuticals, Inc. , a biopharmaceutical company focusing on developing and commercializing products to treat autoimmune diseases, announced the appointment of Steven Engle to and the departure of Dr. James Healy , MD, PhD from its Board of ... [Published 4 Traders - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 02 2014 - 1 reports

PRE 14A - XOMA Corp (0000791908) (Filer)

Document Format FilesSeq Description Document Type Size 1 PRELIMINARY PROXY STATEMENT d701277dpre14a.htm PRE 14A 662920 2 GRAPHIC g701277g74c33.jpg GRAPHIC 7704 Complete submission text file 0001193125-14-126311.txt 674818 ... [Published SEC - Apr 01 2014]
Entities: XOMA (US) LLC
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

XOMA Shares Down 17.9% Since SmarTrend's Sell Call (XOMA)

SmarTrend identified a Downtrend for XOMA (NASDAQ:XOMA) on March 6th, 2014 at $6.75. In approximately 4 weeks, XOMA has returned 17.93% as of today's recent price of $5.54. ... [Published Individual.com - Apr 01 2014]
Entities: XOMA (US) LLC, Stocks
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

XOMA Corp Receives Consensus Rating of “Hold” from Analysts (NASDAQ:XOMA)

XOMA Corp (NASDAQ:XOMA) has been given a consensus rating of "Hold" by the ten ratings firms that are presently covering the stock, AnalystRatings.Net reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating ... [Published American Banking News - Mar 27 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'

A list that might be interesting only to me, but I will share anyway: The biotech and drug stocks getting hit the hardest during the biotech correction -- or whatever you want to call it:Tops on the list is Geron , down 58% in March.GERN data by YCh ... [Published Joshua Star - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 25 2014 - 2 reports

XOMA Down 17.5% Since SmarTrend Downtrend Call (XOMA)

SmarTrend identified a Downtrend for XOMA (NASDAQ:XOMA) on March 6th, 2014 at $6.75. In approximately 3 weeks, XOMA has returned 17.48% as of today's recent price of $5.57. ... [Published Individual.com - Mar 25 2014]
Entities: XOMA (US) LLC
First reported Mar 22 2014 - Updated Mar 22 2014 - 1 reports

Abraxas Petroleum Corp. (AXAS), CAMAC Energy Inc. (CAK), XOMA Corporation (XOMA), Lake Shore Gold Corp. (LSG)

Abraxas Petroleum Corp. (AXAS) recently reported financial and operating results for the three and twelve months ended December 31, 2013 . Net income for the three months ended December 31, 2013 was $27.0 million , or $0.29 per share, compared to a net ... [Published 4 Traders - Mar 22 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

XOMA Corp Shares Down 5.8% After Insider Selling (XOMA)

XOMA Corp (NASDAQ:XOMA) shares traded down 5.8% on Friday after an insider sold shares in the company, AnalystRatingsNetwork reports. The stock traded as low as $5.85 and last traded at $5.87, with a volume of 1,623,222 shares. The stock had previously ... [Published American Banking News - Forex - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 20 2014 - 18 reports

Healthcare Companies Report Financial Results, Partnerships, and Recognitions - Analyst Notes on Keryx, WellCare, Zogenix, Orexigen Therapeutics, and XOMA

SOURCE Analysts ReviewEditor Note: For more information about this release, please scroll to bottom.NEW YORKToday, Analysts Review released its analysts' notes regarding Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), WellCare Health Plans, Inc. (NYSE: ... [Published ABC 3340 - Mar 19 2014]

Quotes

...board in September 2006 , Jim's support and expertise have been immensely helpful to the Company," said Paul F Truex , Anthera's President and CEO. "I join the rest of the management team and Board of Directors in thanking Jim for his numerous contributions and wishing him success in his next endeavors."
...Bradley S Galer, M D , Executive Vice President and Chief Medical Officer of Zogenix, stated, "We congratulate Dr. Stanton on receiving this prestigious award and are proud to have her as part of our Medical Affairs team. She offers a wealth of experience and insight into pain medicine and we look forward to her leadership and guidance as we continue to deliver on our mission of developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions." The full analyst notes on Zogenix Inc. are available to download free of charge at:
"We'd been pretty +ive on XOMA since assuming coverage last August; that said, in the time since, we've seen one too many disappointments. Thus, while also finding the stock fully valued at current levels, we'd like to see more concrete progress with gevo before regaining full confidence in XOMA again.”"
"We rate XOMA CORP (XOMA) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and weak operating cash flow."

More Content

All (81) | News (56) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (1) | Press Releases (16)
sort by: Date | Relevance
Insider Selling: John Varian Unloads 10,000 Sha... [Published American Banking News - 7 hours ago]
Global Hypertension Drugs Market 2014-2018 [Published MarketResearch.com - Apr 15 2014]
Short Interest in XOMA Corp Expands By 43.2% (X... [Published American Banking News - Apr 15 2014]
WEEKLY PORTFOLIO UPDATE: HOW LOW WILL WE GO? [Published Seeking Alpha - Apr 13 2014]
Anthera Pharmaceuticals Announces Personnel Cha... [Published HispanicBusiness.com - Apr 10 2014]
Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) Rides... [Published Live Trading News - Apr 08 2014]
2018 Worldwide Hypertension Drugs Market : Size... [Published PitchEngine - Apr 08 2014]
Anthera Pharmaceuticals : Reports Personnel Cha... [Published 4 Traders - Apr 03 2014]
PRE 14A - XOMA Corp (0000791908) (Filer) [Published SEC - Apr 01 2014]
XOMA Shares Climbing Higher, Up 6.3% [Published Individual.com - Apr 01 2014]
XOMA Shares Down 17.9% Since SmarTrend's Sell C... [Published Individual.com - Apr 01 2014]
ANTHERA PHARMACEUTICALS : Announces Personnel C... [Published 4 Traders - Mar 31 2014]
XOMA Corp Receives Consensus Rating of “Hold” f... [Published American Banking News - Mar 27 2014]
These Stocks Are Getting Hit Hardest During Mar... [Published Joshua Star - Mar 25 2014]
XOMA Down 17.5% Since SmarTrend Downtrend Call ... [Published Individual.com - Mar 25 2014]
Shares of XOMA Under Pressure, Down 10.1% [Published Comtex SmarTrend - Mar 24 2014]
Abraxas Petroleum Corp. (AXAS), CAMAC Energy In... [Published 4 Traders - Mar 22 2014]
XOMA Corp Shares Down 5.8% After Insider Sell... [Published American Banking News - Forex - Mar 21 2014]
XOMA Corp CMO Unloads $111,365 in Stock (XOMA) [Published American Banking News - Mar 20 2014]
XOMA Corp VP Patrick J. Md Phd Scannon Sells 3,... [Published American Banking News - Mar 20 2014]
XOMA Corp CFO Fred Kurland Sells 5,915 Shares (... [Published American Banking News - Mar 20 2014]
Healthcare Companies Report Financial Results, ... [Published ABC 3340 - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published WNEM - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published KWQC - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published WOWK - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published KCEN HD - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published WSFX-TV - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published Fox 19 - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published KTRE - Mar 19 2014]
Healthcare Companies Report Financial Results, ... [Published WVNS - Mar 19 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Xoma to stop testing drug as arthritis treatmen... [Published Yahoo! Health News - Mar 05 2014]
United States drug developer Xoma Corp said it would not proceed with late-stage studies of its lead drug, an antibody called gevokizumab, as a treatment for a form of arthritis of the hand after two mid-stage studies showed the drug was not effec... ...
XOMA Suffers Big Setback [Published Wall St. Cheat Sheet - Mar 05 2014]
While many biotechnology stocks have been generating impressive returns of late, one stock suffered a major setback on Tuesday evening. That company is XOMA Corporation ( NASDAQ:XOMA ). XOMA Corporation is a biotechnology company focused on the ...
Frontrunning: March 5 [Published Zero Hedge - Mar 05 2014]
High Stakes Limit Bid to Cow Putin ( WSJ ) Russia says can't control Crimea troops ahead of U.S. talks ( Reuters ) Crimea Crisis Haunted by Ghosts of Bungled World War I Diplomacy ( BBG ) Putin’s Ukraine Gambit Hurts Economy as Allies Lose Billions  ( ...
Frontrunning: February 25 [Published Zero Hedge - Feb 25 2014]
Turkish PM says tapes of talk with son a fabrication ( Reuters ) but opposition confirms authenticity, and national TV carriers cut parliament when played live Inside the Showdown Atop Pimco, the World's Biggest Bond Firm ( WSJ ) Ex-Jefferies Trader’s ...
Week’s Option Activity (1/13 ~ 1/28) [Published Chimera Research Group - Proceed With Confidence - Jan 28 2014]
The following stocks had notable activity in their options during the past week(s): $XOMA (1/13): 2,550 JUN risk reversals were purchased (stock at $8.32) for 0.40 or $102,000. 2,550. The post Week’s Option Activity (1/13 ~ 1/28) appeared first on ...
1 2

Press Releases

sort by: Date | Relevance
The Zacks Analyst Blog Highlights: Sanofi, Rege... [Published Financial Services - Mar 13 2014]
Technical Roundup - Most Active: J. C. Penney, ... [Published Financial Services - Mar 06 2014]
XOMA Reports 2013 Operational Highlights and Fo... [Published GlobeNewswire: Acquisitions News - Mar 04 2014]
XOMA Provides Update on Gevokizumab Proof-of-Co... [Published GlobeNewswire: Joint Venture News - Mar 04 2014]
XOMA Receives Orphan Drug Designation From U.S.... [Published GlobeNewswire: Acquisitions News - Feb 24 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.